NDC 68788-4113-01 - Dexamethasone
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68788-4113
- Requested NDC
- 68788-4113-01
- Package NDCs from labels
- 68788-4113-6, 68788-4113-1, 68788-4113-5, 68788-4113-3, 68788-4113-01
- Manufacturer
- Preferred Pharmaceuticals Inc
- Effective date
- 2026-06-08
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Dexamethasone - Preferred Pharmaceuticals Inc | Preferred Pharmaceuticals Inc | 2026-06-08 | HUMAN PRESCRIPTION DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Tobradex ST | TOBRAMYCIN / DEXAMETHASONE | Harrow Eye, LLC | 3b99dbb3-ac84-4d0d-b30f-a5db44fdc316 | 2025-04-01 | Warnings, Adverse reactions | 7S5I7G3JQL |
| Dexamethasone | DEXAMETHASONE | Proficient Rx LP | 3f2fe98a-ab42-4bec-bf97-c090567f9ad6 | 2025-04-01 | Warnings, Adverse reactions | 197582 7S5I7G3JQL |
| Dexamethasone | DEXAMETHASONE | Bionpharma Inc., | 401ec088-984a-49ab-b317-747c2b9b9e22 | 2025-03-05 | Warnings, Adverse reactions | 7S5I7G3JQL |
| Dexamethasone | DEXAMETHASONE | Bionpharma Inc., | 3166db4f-66a5-496a-a194-3cc01b7347d3 | 2025-03-05 | Warnings, Adverse reactions | 197582 197583 7S5I7G3JQL |
| Ciprofloxacin and Dexamethasone | CIPROFLOXACIN AND DEXAMETHASONE | NuCare Pharmaceuticals, Inc. | 2f780550-ecbf-98fc-e063-6294a90a11c0 | 2025-03-03 | Warnings, Adverse reactions | 7S5I7G3JQL |
| Alcostat | TARAXACUM OFFICINALE, AVENA SATIVA, PASSIFLORA INCARNATA, AURUM METALLICUM, CAPSICUM ANNUUM, CHELIDONIUM MAJUS, LACHESIS MUTUS, LYCOPODIUM CLAVATUM, NOX VOMICA, QUERCUS GLANDIUM SPIRITUS, SULPHURICUM ACIDUM, ETHYLICUM, CARCINOSIN, SACCHARUM OFFICINALE | Energique, Inc. | 77daea02-3c32-4ba3-a7a8-af79b13ddc06 | 2025-02-27 | Warnings | C151H8M554 |
| Neomycin and Polymyxin B Sulfates and Dexamethasone | NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND DEXAMETHASONE | Sandoz Inc. | cf1a6da8-ba79-4bff-a13b-6effb67f6c1c | 2025-02-20 | Warnings, Adverse reactions | 7S5I7G3JQL |
| Dexamethasone | DEXAMETHASONE | Preferred Pharmaceuticals Inc. | b883860c-27ba-4bac-8ae3-4cf4d82d5071 | 2025-02-10 | Warnings, Adverse reactions | 197582 7S5I7G3JQL |
| Tobramycin and Dexamethasone | TOBRAMYCIN AND DEXAMETHASONE | NuCare Pharmaceuticals,Inc. | b7b39ad5-e158-b8fe-e053-2995a90a5279 | 2025-02-07 | Warnings, Adverse reactions | 7S5I7G3JQL |
| Dexamethasone | DEXAMETHASONE | Prasco Laboratories | bfce6b49-f7ff-4ec7-9580-b730f0a207d7 | 2025-02-01 | Warnings, Adverse reactions | 197582 7S5I7G3JQL |
| Ciprofloxacin and Dexamethasone | CIPROFLOXACIN AND DEXAMETHASONE | Sandoz Inc | 89fef4d2-7078-47f1-96bf-aca50b135a97 | 2025-01-31 | Warnings, Adverse reactions | 7S5I7G3JQL |
| Dexamethasone | DEXAMETHASONE | Redpharm Drug, Inc. | 115e1bfb-1697-d567-e063-6394a90a78e5 | 2025-01-23 | Warnings, Adverse reactions | 197582 7S5I7G3JQL |
| Dexamethasone | DEXAMETHASONE | Direct_Rx | e90cb7f5-5e99-fbf3-e053-2995a90a70aa | 2025-01-22 | Warnings, Adverse reactions | 343033 7S5I7G3JQL |
| Dexamethasone | DEXAMETHASONE | Direct_Rx | fade983c-81fb-df94-e053-6394a90a7560 | 2025-01-22 | Warnings, Adverse reactions | 197580 7S5I7G3JQL |
| Dexamethasone | DEXAMETHASONE | Direct_Rx | 044d7898-4ab6-a0b3-e063-6294a90acdba | 2025-01-22 | Warnings, Adverse reactions | 197582 7S5I7G3JQL |
| Anise Pyrite | ANISE PYRITE | Uriel Pharmacy Inc. | a03cdeb0-8347-40cc-8d17-5510d99575c7 | 2025-01-22 | Warnings | C151H8M554 |
| DEXAMETHASONE | DEXAMETHASONE | Direct Rx | cc7140de-a205-f675-e053-2995a90ac22b | 2025-01-20 | Warnings, Adverse reactions | 197582 7S5I7G3JQL |
| Tobradex ST | TOBRAMYCIN / DEXAMETHASONE | Eyevance Pharmaceuticals, LLC | c2d7325e-4f58-5590-e053-2a95a90ace1b | 2025-01-16 | Warnings, Adverse reactions | 7S5I7G3JQL |
| Dexamethasone | DEXAMETHASONE | Preferred Pharmaceuticals Inc. | 955db121-79f4-47eb-8c10-01b2d8b411e4 | 2025-01-13 | Warnings, Adverse reactions | 343033 7S5I7G3JQL |
| A-5 | SUCROSE | DNA Labs, Inc. | 8e63f697-26c1-4518-acd3-5ea72cfa27f7 | 2025-01-09 | Warnings | C151H8M554 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.